Don’t miss the latest developments in business and finance.

Bleak Q4 figures hit Aurobindo Pharma

DALAL STREET SPIKES

Image
Our Markets Bureau Mumbai
Last Updated : Feb 06 2013 | 7:38 PM IST
Subdued market sentiment and disappointing fourth quarter results pulled Aurobindo Pharma down 3.70 per cent in today's trading. The stock in intra-day trades touched a low of Rs 346 before closing at Rs 359.60.
 
The counter witnessed volumes of more than 59 thousand shares at the BSE and 1.88 lakh shares at the NSE. Analysts said, disappointing Q4 results propelled selling by market participants.
 
The company for the quarter ended March 31 reported a decline in net profit at Rs 36.22 crore as against Rs 46.37 crore in the same period last year.
 
The counter was also under selling pressure on overall weakness in the market sentiment as investors are looking at exit options at every higher levels.
 
For the year ended March 31, the company's net profit stood at Rs 127.01 crore as against Rs 103.14 crore on total income of Rs 1,363.13 crore.

 
 

Also Read

First Published: Jun 04 2004 | 12:00 AM IST

Next Story